A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.
NCT05025787
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Knee Osteoarthritis
Interventions
DRUG:
CNTX-6970
DRUG:
Placebo
Sponsor
Maurizio Fava, MD